Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of Santarsiero, Bernard

Bernard Santarsiero

Research Professor, Department of Pharmaceutical Sciences | Director, Research Initiatives, Graduate College | Institute Affiliate, Pharmacognosy Institute

Research Interests Heading link

My expertise is at the interface between structural chemistry and structural biology with a long-term research objective to foster and develop all aspects of drug discovery, including target selection, robotics, high-throughput screening, assay development, and computational methodologies. Focusing on human health, I have collaborated or led projects addressing infectious and neurodegenerative disease, natural products, cancer chemoprevention, and diabetes. As a co-founder of a small drug discovery company, Syrrx, and founding group leader of the Novartis Institute for Functional Genomics, we developed two new drugs, alogliptin and pioglitazone. More recently, over the past decade, I have been on leadership teams that seek to reduce the equity gaps of students of color in higher education, and have helped to develop a number of new programs at UIC, e.g., L@s GANAS, DuSable Scholars, PBRC-PREP.


PhD (1980) University of Washington